(All fields required)
Please enter a valid email.
Please enter your name.
The Diabetes Center is home to specialists with a wide variety of backgrounds and areas of focus. As a team, this diversity makes us better prepared to care for your child’s unique needs. Learn more about our faculty and staff.
Philippe F. Backeljauw, MD Fellowship Program Director, Division of Endocrinology 513-636-8444 email@example.com
Fellowship Program Director, Division of Endocrinology
Clinical Director, Cincinnati Growth Center
Director, Turner Syndrome Center of Cincinnati
Professor, UC Department of Pediatrics
Pediatric endocrinology; growth disorders; Turner syndrome
Dr. Backeljauw's research has focused on clinical trials evaluating the efficacy and safety of recombinant human IGF-I in patients with growth hormone insensitivity syndrome. These studies have led to the USFDA approval of IGF-I as a treatment for growth failure associated with primary IGF-I deficiency. The studies ended in 2012, and results have been published. He has also been involved in other multicenter studies of IGF-I therapy or combined growth hormone plus IGF-I therapy for idiopathic short stature. In collaboration with Dr. Meilan Rutter, they recently finished a comprehensive study looking at the efficacy and safety of IGF-I therapy in patients with Duchenne muscular dystrophy.
Another area of research for Dr. Backeljauw, during the last five years, is related to activities in the Turner Syndrome Center. We now have conducted several clinical research projects evaluating the cardiovascular pathology, hypertension, attention deficit disorder status, gonadectomy surgery outcomes, and, in particular, vasculopathy prevalence in our large cohort of patients with Turner syndrome.
Lawson S, Little I, Urbina E, Khoury P, Backeljauw PF. Vasculopathy in the young Turner syndrome population. J Clin Endocrinol Metab. 2014 Oct;99(10):E2039-45.
Chen J, Gutmark E, Myalavarapu G, Backeljauw PF, Gutmark-Little I, Gutmark E. Numerical investigation of mass transport through patient-specific deformed aortae. J Biomech. 2014 Jan 22:47(2):544:52.
Sisley S, Backeljauw PF. Response to Letter to the Editor: Low incidence of pathology detection and high cost of screening in the evaluation of asymptomatic children with short stature. J Pediatr. 2013 Nov; 163(5):1535.
Backeljauw PF, Kuntze J, Frane J, Calikoglu A, Chernausek SD. The recommended dose for IGF-I therapy does not compromise long-term growth. Letter to the editor. J Clin Endocrinol Metab. July 18, 2013.
Sisley S, Vargas-Trujillo M, Khoury J, Backeljauw PF. Low incidence of pathology detection and high cost of screening in the evaluation of asymptomatic children with short stature. J Pediatr. 2013;163(4): 1045-1051.
Backeljauw PF, Chernausek SD, Calikoglu A, Kuntze J, Frane J. Adult height in patients with severe primary IGF-I deficiency. Horm Res Paediatr. 2013;80(1): 47-56.
Prahl Wittberg L, van Wyk S, Mihaescu M, Fuchs, L, Gutmark E, Backeljauw P, Gutmark-Little I. The impact of aortic arch geometry on flow characteristics. American Institute of Aeronautics and Astronautics, 51st AIAA Aerospace Sciences Meeting Proceedings. 2013;1-16.
Gutmark-Little I, Backeljauw P. Cardiac magnetic resonance imaging in Turner syndrome. Clin Endocrinol (Oxf). 2013;78, 646–58.
Gutmark-Little I, Hor K, Gottliebson W, Cnota J, Gottliebson WM, Backeljauw PF. Partial anomalous pulmonary venous return is common in Turner syndrome. J Pediatr Endocrinol Metab. 2012;25 (5-6):435-40.
Bang P, Ahmed F, Argente J, Backeljauw P, Bettendorf M, Bona G, Coutant R, Rosenfeld RG, Walenkamp MJ, Savage MO. Identification and management of poor response to growth-promoting therapy in children with short stature. Clin Endocrinol (Oxf). 2012;77:169-81.
Nancy A. Crimmins, MD 513-636-4744 firstname.lastname@example.org
Assistant Professor, UC Department of Pediatrics
MD: Indiana University School of Medicine, 2000.
Residency: Pediatrics, Cincinnati Children's Hospital Medical Center, 2003.
Fellowship: Pediatric Endocrinology, Cincinnati Children's Hospital Medical Center, 2006.
Namjou B, Keddache M, Marsolo K, Wagner M, Lingren T, Cobb B, Perry C, Kennebeck S, Holm IA, Crimmins NA, Martin L, Solti I, Kohane IS, Harley JB. EMR-linked GWAS study: investigation of variation landscape of loci for body mass index in children. Frontiers in Genetics. 2013 Dec 3;4268.
Chuang J, Zellar MH, Inge T, Crimmins NA. Bariatric Surgery for Severe Obesity in Two Adolescents with Type 1 Diabetes. Pediatrics. 2013 Oct;132(4):e1031-4.
Maahs DM, Dabelea D, D’Agostino RB, Andrews JS, Shah AS, Crimmins NA,
Mayer-Davis EJ, Marcovina S, Imperatore G, Wadwa RP, Daniels SR,
Reynolds K, Hamman RF, Dolan LM. Glucose Control Predicts 2-Year Change in Lipid Profile in Youth with Type 1. J Pediatr. 2013 Jan;162(1):101-7.
Kottyan LC, Woo JG, Keddache M, Banach W, Crimmins NA, Dolan LM, Martin LJ. Novel Variations in the Adiponectin Gene (ADIPOQ) May Affect Distribution of Oligomeric Complexes. Springerplus. 2012 Dec;1(1):66.
Pettitt DJ, Talton JW, Liese AD, Liu LL, Crimmins NA, West NA, D’Agostino RB, Kahn HS for the SEARCH for Diabetes in Youth Study Group. Comparison of Two Waist Circumference Measurement Protocols: The SEARCH for Diabetes in Youth Study. International Journal of Pediatric Obesity. 2012 Sept.
Guilfoyle SM, Crimmins NA, Hood KK. Blood glucose monitoring and glycemic control in adolescents with type 1 diabetes: meter downloads versus self-report. Pediatr Diabetes. 2011 Sep;12(6):560-6.
Sung V, Beebe DW, Vandyke R, Fenchel MC, Crimmins NA, Kirk S, Hiscock H, Amin R, Wake M. Does sleep duration predict metabolic risk in obese adolescents attending tertiary services? A cross-sectional study. Sleep. 2011 Jul 1;34(7):891-8.
Sabin MA, Clemens SL, Saffery R, McCallum Z, Campbell MW, Kiess W, Crimmins NA, Woo JG, Leong GM, Werther GA, Ukoumunne OC, Wake MA. New directions in childhood obesity research: how a comprehensive biorepository will allow better prediction of outcomes. BMC Med Res Methodol. 2010 Oct 22;10:100.
Lawrence M. Dolan, MD Director, Division of Endocrinology 513-636-4744
Director, Division of Endocrinology
Director, Endocrinology Clinical Laboratory
Pediatric endocrinology; diabetes mellitus
Lawrence M. Dolan, MD, is board-certified in pediatrics and pediatric endocrinology. He has been on the faculty of Cincinnati Children's Hospital Medical Center in the Department of Pediatrics for the University of Cincinnati College of Medicine since 1983.
Dr. Dolan is a professor of pediatrics in the Division of Endocrinology. His research focuses on the epidemiology and genetics of obesity, insulin resistance, abnormal carbohydrate metabolism, diabetes and their relationships to the development and progression of cardiovascular disease.
Dr. Dolan received his bachelor of science degree from the University of San Francisco. He received his doctor of medicine degree from the University of California at Los Angeles.
Dr. Dolan completed his pediatric internship and residency at the University of Minnesota. He also served as chief resident. He obtained fellowship training in pediatric endocrinology at the University of Virginia.
Valenzuela JM, Smith LB, Stafford JM, D'Agostino RB Jr, Lawrence JM, Yi-Frazier JP, Seid M, Dolan LM. Shared decision-making among caregivers and health care providers of youth with type 1 diabetes. J Clin Psychol Med Settings. 2014 Sep;21(3):234-43.
Shah AS, Dabelea D, Talton JW, Urbina EM, D’Agostino RB, Wadwa RP, Marcovina S, Hamman RF, Daniels SR, Dolan LM. Smoking and Arterial Stiffness in Youth with Type 1 Diabetes: the SEARCH Cardiovascular Disease Study. J Pediatr. 2014 Jul;(1)165:110-6.
Lawrence JM, Imperatore G, Dabelea D, Mayer-Davis EJ, Linder B, Saydah S, Klingensmith GJ, Dolan L, Standiford DA, Pihoker C, Pettitt DJ, Talton JW, Thomas J, Bell Ra, D’Agostino RB Jr, SEARCH for Diabetes in Youth Study Group. Trends in Incidence of Type 1 Diabetes Among non-Hispanic White Youth in the United States, 2002-2009. Diabetes. 2014 Nov;63(11):3938-45.
Rohan JM, Rausch JR, Shroff Pendley J, Delamater A, Dolan L, Reeves G, Drotar D. Identification and Prediction of Group-Based Glycemic Control Trajectories during the Transition to Adolescence. Health Psychol. 2014 Oct;33(10):1143-52.
Dabelea D, Mayer-Davis EJ, Saydah S, Imperatore G, Linder B, Divers J, Bell R, Badaru A, Talton JW, Cume T, Leise AD, Merchant AT, Lawrence JM, Reynolds K, Dolan L, Liu LL, Hamman RF, SEARCH for Diabetes in Youth Study. Prevalence of type 1 and type 2 diabetes among children and adolescents from 2001 to 2009. JAMA. 2014 May 7;311:1778-86.
Shah AS, Gao Z, Urbina EM, Kimball TR, Dolan LM. Prediabetes: The Effects on Arterial Thickness and Stiffness in Obese Youth. J Clin Endocrinol Metab. 2014 Mar;99(3):1037-43.
Dabelea D, Lawrence JM, Pihoker C, Dolan L, D’Agostino Jr RB, Marcovina S, Mayer-Davis EJ, SEARCH for Diabetes in Youth Study. Re: “Prevalence of Diagnosed and Undiagnosed Type 2 Diabetes Mellitus Among US Adolescents: Results from the Continuous NHANES, 1999-2010”. Am J Epidemiol. 2014 Feb 1;179:396-7.
Inge TH, Zeller MH, Jenkins TM, Helmrath M, Brandt ML, Michalsky MP, Harmon CM, Courcoulas A, Horlick M, Xanthacos SA, Dolan L, Mitsnefes M, Barnett SJ, Bunchar R, Teen-LABS Consortium. Perioperative Outcomes of Adolescents Undergoing Bariatric Surgery: The Teen-Longitudinal Assessment of Bariatric Surgery (Teen-LABS) Study. JAMA Pediatr. 2014 Jan;168:47-53.
Corathers SD, Kichler J, Jones N, Houchen A, Jolly M, Morwessel N, Crawford P, Dolan LM, Hood KK. Improving Depression Screening for Adolescents with Type 1 Diabetes. Pediatrics. 2013 Nov;132(5):e1395-402.
Gordon SM, Davidson WS, Urbina EM, Dolan LM, Lu JL, Heink A, Zang H, Shah AS. The effects of type 2 diabetes on lipoprotein composition and arterial stiffness in male youth. Diabetes. 2013 Aug;62(8):2958-67.
SEARCH for Diabetes in Youth. Principal Investigator. Center for Disease Control and the National Institutes of Health. Sep 2010–Oct 2015. 3 (1U18DP002709).
Accelerated cardiovascular aging in Youth. Co-investigator. National Institutes of Health. Jan 2011–Dec 2015. R01-105591.
Adolescent Bariatric Surgery: Assessing Benefits and Risks. Co-investigator. National Institutes of Health. Apr 2012–Mar 2017. UO1DK072493.
Self-management of type 1 diabetes during adolescence. Co-investigator. National Institutes of Health. Jul 2013–Jun 2018. R01DK069486-06.
SEARCH for Air. Co-investigator. National Institutes of Health. Sep 2011–Jun 2015. RO1ES019168.
Deborah A. Elder, MD 513-636-4744 email@example.com
Type 1 diabetes; type 2 diabetes; cystic-fibrosis-related diabetes; assessment of beta-cell function in the evaluation of total pancreatectomy and islet autotransplantation (TPAIT) in children with chronic pancreatitis; growth disorders; precocious puberty; pancreatic center member; cystic fibrosis and endocrine combined clinic; lung transplantation center member.
BS: Michigan State University, 1991.
MD: University of Kentucky College of Medicine, Lexington, KY, 1995.
Residency: Indiana University Riley Hospital For Children, Indianapolis, IN, 1998.
Fellowship: University of North Carolina at Chapel Hill, Chapel Hill, NC, 2001.
Certification: Pediatric endocrinology.
Auble B, Elder D, Gross A, Hillman JB. Differences in the Management of Adolescents with Polycystic Ovary Syndrome across Pediatric Specialties. J Pediatr Adolesc Gynecol. 2013 May 28.
Elder DA, Herbers P, Weis T, Standiford D, Woo JG, D’Alessio DA. Beta-cell function in adolescent and adults with newly diagnosed type 2 diabetes mellitus. J. Pediatr. June 2012;160(6):904-10.
Elder DA, Woo JG, D’Alessio DA. Impaired beta-cell sensitivity to glucose and maximal insulin secretory capacity in adolescents with type 2 diabetes. Ped Diabetes. 2010; 11(5):314-21.
Elder DA, D’Alessio DA, Eyal O, Mueller R, Smith FO, Kansra AR, Rose SR. Abnormalities in Glucose Tolerance Are Common in Children with Fanconi Anemia and Associated with Impaired Insulin Secretion. Pediatric Blood & Cancer. 2008; 51(2):256-60.
Elder DA, Wooldridge JL, Dolan LM, D’Alessio DA. Glucose Tolerance in Children and Adolescents with Cystic Fibrosis and No Prior History of Diabetes. J Pediatr. 2007;151(6):653-8.
Elder DA, Prigeon RL, Wadwa RP, Dolan LM, D’Alessio DA. Beta-cell Function, Insulin Sensitivity and Glucose Tolerance in Obese Diabetic and Nondiabetic Adolescents and Young Adults. J Clin Endocrinol Metab. 2006;91(1):185-91.
Eyal O, Naffaa LN, Elder DA. A Case of Macroprolactinoma and Elevated Insulin-Like Growth Factor-I in a Young Boy. Acta Paediatr. 2005;94(12):1852-6.
Elder DA, Roper MG, Henderson RC, Davenport ML. Kyphosis in a Turner Syndrome Population. Pediatrics. 2002;109(6):e93.
Elder DA, Kaiser-Rogers K, Aylsworth AS, Calikoglu AS. Type 1 diabetes mellitus in a patient with chromosome 22q11.2 deletion syndrome. American Journal of Medical Genetics. 2001; 101(1):17-9.
Elder DA, Karayal AF, D’Ercole AJ, Calikoglu AS. Effects of hypothyroidism on insulin-like growth factor-I expression during brain development in mice. Neuroscience Letters. 2000; 293(2):99-102.
Jonathan D. Katz, PhD 513-636-5306 firstname.lastname@example.org
T cells; MHC, beta cell death; islet antigens
Jonathan D. Katz, PhD, focuses on autoimmune diabetes research. Autoimmune diabetes, also known as type 1 diabetes (T1D), is the most common pediatric autoimmune disease. Roughly 1/250 individuals develop T1D in the United States.There is currently no cure for T1D and the only treatment is daily exogenous insulin replacement therapy. Many T1D patients eventually develop secondary complications, such as hearth disease, blindness, peripheral neuropathy and renal failure.
Dr. Katz's work focuses on the role that autoreactive T lymphocytes play in the disease process. His lab interested in (1) the control of autoreactive T cells via central and peripheral tolerance, (2) the role NKT cells play in regulating autoreactive T cells, and (3) the role dendritic cells play in activating and regulating autoreactive T cells in T1D.
Most of his work uses the non-obese diabetic (NOD) mouse strain that spontaneously develops T1D with remarkable similar to the T1D seen in human patients. The availability of the NOD strain has allowed us to take a modern, reductionist molecular and cellular immunology approach to understanding the mechanism(s) and genetics underlying T1D susceptibility and disease progression. His lab makes extensive use of knockout, transgenic, regulated gene expression, targeted ablation, cell transfer and genomic studies the progression and regulation of T1D in the NOD mouse.
BS: University of California, Los Angeles, CA, 1984.
PhD: University of California, Los Angeles, CA, 1990.
Post-Doctoral Fellow: Université Louis Pasteur, Strasbourg, France, 1990-1995.
Katz JD, Ondr JK, Opoka RJ, Garcia Z, Janssen EM. Cutting edge: merocytic dendritic cells break T cell tolerance to beta cell antigens in nonobese diabetic mouse diabetes. J Immunol. 2010 Aug 15;185(4):1999-2003.
Pang S, Zhang L, Wang H, Yi Z, Li L, Gao L, Zhao J, Tisch R, Katz JD, Wang B. CD8(+) T cells specific for beta cells encounter their cognate antigens in the islets of NOD mice. Eur J Immunol. 2009 Oct;39(10):2716-24.
Saxena V, Ondr JK, Magnusen AF, Munn DH, Katz JD. The countervailing actions of myeloid and plasmacytoid dendritic cells control autoimmune diabetes in the nonobese diabetic mouse. J Immunol. 2007 Oct 15;179(8):5041-53.
Wojciechowski S, Tripathi P, Bourdeau T, Acero L, Grimes HL, Katz JD, Finkelman FD, Hildeman DA. Bim/Bcl-2 balance is critical for maintaining naive and memory T cell homeostasis. J Exp Med. 2007 Jul 9;204(7):1665-75.
Cain JA, Smith JA, Ondr JK, Wang B, Katz JD. NKT cells and IFN-gamma establish the regulatory environment for the control of diabetogenic T cells in the nonobese diabetic mouse. J Immunol. 2006 Feb 1;176(3):1645-54.
Vukkadapu SS, Belli JM, Ishii K, Jegga AG, Hutton JJ, Aronow BJ, Katz JD. Dynamic interaction between T cell-mediated beta-cell damage and beta-cell repair in the run up to autoimmune diabetes of the NOD mouse. Physiol Genomics. 2005 Apr 14;21(2):201-11.
Hutton JJ, Jegga AG, Kong S, Gupta A, Ebert C, Williams S, Katz JD, Aronow BJ. Microarray and comparative genomics-based identification of genes and gene regulatory regions of the mouse immune system. BMC Genomics. 2004 Oct 25;5(1):82.
Susan R. Rose, MD Member, Division of Endocrinology 513-636-4744 email@example.com
Member, Division of Endocrinology
Neuro-endocrinology; hypothalamic-pituitary injury; growth disorders; puberty disorders; thyroid disorders; late effects of cancer
Susan Rose is professor in the Division of Endocrinology at Cincinnati Children’s Hospital Medical Center and the University of Cincinnati. She has published over 100 review articles or chapters, and about 100 peer-reviewed articles. These include updating guidelines for care of congenital hypothyroidism and writing the chapter on thyroid for Fanaroff's and Avery's textbooks of neonatology. She’s served on the state newborn screening (NBS) committee in Tennessee. She is involved in long term follow up of newborn screening for CAH and congenital hypothyroidism with Region 4 and with the Federal Workgroup on NBS Standards.
She has clinical expertise and research interests in hypothalamic pituitary function, thyroid hormone disorders, and in disorders of growth or puberty. She has a special interest in the effects of central nervous system injury on hypothalamic-pituitary function. In addition, she has expertise and experience in evaluating the endocrine conditions associated with congenital bone marrow failure syndromes such as Fanconi anemia, Blackfan Diamond anemia, and Shwachman-Diamond syndrome. In addition, she is evaluating the endocrine consequences of hypothalamic-pituitary injury, including traumatic brain injury and injury from treatments for cancer, as well as comparing the relative efficacy of several treatments for precocious puberty. In this study, she will be developing growth curves specific to Fanconi Anemia, recognizing that healthy children with FA may not grow along the typical growth pattern of other healthy children.
MD: Case Western Reserve School of Medicine, 1980.
MEd: School Psychology, University of Dayton, 1972.
Residency: The Cleveland Clinic, 1983.
Fellowship: National Institutes of Health, 1986.
Certification: Pediatrics, 1985; Pediatric Endocrinology, 1986.
Auble BA, Makoroff K, Bollepalli S, Weis T, Colliers T, Khoury J, Rose SR. Hypopituitarism in pediatric survivors of inflicted traumatic brain injury. J Neurotrauma. 2014 Feb 15;31(4):321-6.
Myers KC, Rose SR, Rutter MM, Mehta PA, Cole T, Harris RE. Endocrine evaluation of children with and without Shwachman-Bodian-Diamond syndrome gene mutations and Shwachman-Diamond syndrome. J Pediatr. 2013 Jun;162(6):1235-40.
Rutter MM, Collins J, Rose SR, Woo JG, Sucharew H, Sawnani H, Hor KN, Cripe LH, Wong BL. Growth hormone treatment in boys with Duchenne muscular dystrophy and glucocorticoid-induced growth failure. Neuromuscul Disord. 2012 Dec;22(12):1046-56.
Rose SR, Myers K, Rutter MM, Mueller R, Khuory JC, Mehta PA, Harris RE, Davies SM. Endocrine phenotype of children and adults with Fanconi anemia. Pediatr Blood Cancer. 2012 Oct;59(4):690-6.
Merchant TE, Rose SR, Bosley C, Wu S, Xiong X, Lustig RH. Growth hormone secretion after conformal radiation therapy in pediatric patients with localized brain tumors. J Clin Oncol. 2011 Dec 20;29(36):4776-80.
Kaulfers AM, Backeljauw PF, Reifschneider K, Blum S, Michaud L, Weiss M, Rose SR. Endocrine dysfunction following traumatic brain injury in children. J Pediatr. 2010 Dec;157(6): 894-9.
Rose SR. Improved diagnosis of mild hypothyroidism using time-of-day normal ranges for thyrotropin. J Pediatr. 2010 Oct;157(4):662-7.
Slaughter JL, Meinzen-Derr J, Rose SR, Leslie ND, Chandrasekar R, Linard SM, Akinbi HT. The effects of gestational age and birth weight on false-positive newborn screening rates. Pediatrics. 2010 Nov;126(5):910-6.
Kazlauskaite R, Evans AT, Villabona CV, Abdu TAM, Ambrosi B, Atkinson AB, Choi CH, Courtney CH, Gonc EN, Maghnie M, Oelkers W, Rose SR, Soule SG, Tordjman K, Consortium for evaluation of corticotropin test in hypothalamic-pituitary insufficiency. Corticotropin tests for hypothalamic-pituitary adrenal insufficiency: A metaanalysis. J Clin Endocrinol Metab. 2008 Nov;93(11):4245-53.
Rose SR. Pharmacologic and physiologic regulators of the nocturnal TSH surge; A clinical research center study. Recent Advances and Research Updates. ISSN 0972-4699, 2007; 8:219-29.
Meilan M. Rutter, MD Member, Division of Endocrinology 513-636-4744 firstname.lastname@example.org
Bone health and calcium metabolism; disorders of growth, puberty and sex development; endocrine function in cancer survivors; endocrine function in neuromuscular disorders
Meilan Rutter is board-certified in pediatrics and pediatric endocrinology. She is an assistant professor of pediatrics in the Division of Endocrinology, and joined the faculty of Cincinnati Children's Hospital Medical Center in 2008. Currently, Dr. Rutter is assistant director of the Pediatric Endocrinology Fellowship Program.
Dr. Rutter received her degrees of Bachelor of Medicine and Bachelor of Surgery (MB, BCh) from the University of Wales College of Medicine. She completed her training in pediatrics in New Zealand, and was admitted to Fellowship of the Royal Australasian College of Physicians (FRACP) in 1995. She underwent fellowship training in pediatric endocrinology at Cincinnati Children's. She completed further pediatric residency training to achieve American Board of Pediatrics specialty and subspecialty board certification.
Dr. Rutter treats children and adolescents with endocrine disorders and diabetes mellitus. She serves as a consultant for the Neuromuscular Comprehensive Care Center and the Neuro-Oncology Program at Cincinnati Children's. Additionally, she is a member of the Disorders of Sex Development Center's interdisciplinary team.
MB, BCh: University of Wales College of Medicine, Cardiff, United Kingdom.
FRACP: Royal Australasian College of Physicians, New Zealand.
Residency: Auckland Children's Hospital and Dunedin Hospital, New Zealand; Cincinnati Children's, Cincinnati, OH.
Fellowship: Pediatric Endocrinology, Cincinnati Children's, Cincinnati, OH.
Certification: General Pediatrics, American Board of Pediatrics, 2002; Pediatric Endocrinology, American Board of Pediatrics, 2003; Pediatrics, Fellowship of the Royal Australasian College of Physicians, 1995.
Rose SR, Rutter MM, Mueller R, Harris M, Hamon B, Fletcher Bulluck A, Smith FO. Bone mineral density is normal in children with Fanconi anemia. Pediatr Blood Cancer. 2011 Dec 1;57(6):1034-8.
Bianchi ML, Biggar D, Bushby K, Rogol AD, Rutter MM, Tseng B. Endocrine aspects of Duchenne Muscular Dystrophy. Neuromuscul Disord. 2011 Apr;21(4):298-303.
Wong BL, Rutter MM, Rose SR, Clark E, Vonderhaar K. Growth hormone therapy in Duchenne Muscular Dystrophy. Best Evidence Statement, Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio. 2009.
Rutter MM. What is an endocrinologist and why is endocrine care important for Duchenne? Action Duchenne newsletter. 2009.
Murray R, Rutter MM, Racine M, Rose SR. Report on The Endocrine Society’s 90th Annual Meeting. Highlights. 2008;16(4):1-36.
Rutter MM, Racine M, Rose SR. Report on The Endocrine Society’s 89th Annual Meeting. Highlights. 2007;15(3):2-30.
Rutter MM, Rose SR. Long-term endocrine sequelae of childhood cancer. Curr Opin Pediatr. 2007 Aug;19(4):480-7.
Rutter MM, Markoff E, Clayton L, Akeno N, Zhao G, Clemens TL, Chernausek SD. Osteoblast-specific expression of insulin-like growth factor-1 in bone of transgenic mice induces insulin-like growth factor binding protein-5. Bone. 2005 Feb;36(2):224-31.
Rutter MM, Prahalad S, Passo M, Backeljauw PF. Idiopathic hypercalcemia and eosinophilic fasciitis: a novel association. J Pediatr Endocrinol Metab. 2004 Sep;17(9):1251-4.
Rutter MM, Smith EP. Pseudohypoparathyroidism type Ia: late presentation with intact mental development. J Bone Miner Res. 1998 Jul;13(7):1208-9.
Peggy Joyce Stenger, DO 513-636-4744 email@example.com
BS: University of Texas, Arlington, Texas.
DO: Texas College of Osteopathic Medicine, Fort Worth, Texas.
Residency: Pediatrics, Children's Hospital of New Mexico, Albuquerque, NM.
Fellowship: Pediatric Endocrinology, Children's Hospital Medical Center, Cincinnati, OH.
CCD: International Society Clinical Densitometry.
Certification: General Pediatrics, American Board of Pediatrics 1989; Pediatric Endocrinology, American Board of Pediatrics 1999; International Society Clinical Densitometry 2007.
Nana-Hawa Yayah Jones, MD 513-636-4744 firstname.lastname@example.org
Diversity and cultural competence; non-adherence in the pediatric population; information technology in healthcare; medical education
Adherence in youth with type 1 diabetes
Nana-Hawa Yayah Jones, MD, is a new clinical faculty in the division of pediatric endocrinology. Dr. Yayah Jones recently arrived in Cincinnati from St. Louis, Missouri where she completed both pediatric residency and endocrinology fellowship at Washington University's St. Louis Children's Hospital (SLCH). An additional year was spent at SLCH as a pediatric chief resident. During all the years of Dr. Yayah Jones's training she was active in fostering diversity among the medical trainees and in fact founded the Washington University Minority Medical Association (WUMMA), a group of medical trainees whose focus was on recruitment, retention and community service. As creator and president of WUMMA she became active in the resident and fellows diversity initiative created by the Barnes Jewish Hospital Center for Diversity and Cultural Competence. She mentored undergraduate student, medical students and residents throughout her training.
During fellowship she fostered a special interest in children with chronic illness who are non-adherent to their medical regimen. Dr. Yayah Jone's research efforts will be geared towards the non-adherence type 1 diabetic who is often prone to recurrent hospitalizations and diabetes complications.
Janise M. Felblinger, MSN, APRN, CNP Nurse Practitioner, Diabetes Center 513-636-2444 email@example.com
Nurse Practitioner, Diabetes Center
BSN: Xavier University, 2003.
MSN: University of Cincinnati, 2009.
Certification: Pediatric Nursing Certification Board, 2009.
Michele Hanson, MSN, APRN, CNP Nurse Practitioner, Diabetes Center 513-636-2444 firstname.lastname@example.org
BSN: Wright State University, Dayton, OH, 1984.
MSN: University of Cincinnati, Cincinnati, OH, 1991.
Certification: Pediatric Nurse Practitioner, 1991.
Jennifer J. Kelly, MSN, APRN, CNP Nurse Practitioner, Division of Endocrinology 513-636-2444 email@example.com
Nurse Practitioner, Division of Endocrinology
MSN: The Ohio State University, Columbus, OH, 2003.
Certification: CNP, 2004 PNCB.
Ann B. Malinowski, MSN, APRN, CNP Nurse Practitioner, Division of Endocrinology 513-636-2444 firstname.lastname@example.org
BSN: University of Kentucky, Lexington, KY, 1977.
MSN:University of Cincinnati, Cincinnati, OH, 1981.
Certification: Pediatric Nurse Practitioner, 1981.
Nancy J. Morwessel, MSN, APRN, CNP Pediatric Nurse Practitioner, Diabetes Center 513-636-2444 email@example.com
Pediatric Nurse Practitioner, Diabetes Center
General pediatric diabetes care and intensified insulin therapy; quality-of-life and well-being measurement; bioethics consultation and education; bereavement follow-up.
BSN: University of Cincinnati, Cincinnati, OH, 1975.
MSN: Child Health Nursing, University of Cincinnati, Cincinnati, OH, 1981.
Certification: Pediatric Nurse Practitioner, 1981.
Christine D. Osborn, RN, APRN, CNP Nurse Practitioner, Division of Endocrinology 513-636-2444 firstname.lastname@example.org
MS: University of Cincinnati, Cincinnati, OH, 1992.
CNP: The Ohio State University, Columbus, OH, 1997.
Certification: Pediatric Nurse Practitioner, National Certification Board of Pediatric Nurse Practitioners and Nurses, 1997.
Debra A. Standiford, MSN, APRN, CNP Pediatric Nurse Practitioner, Diabetes Center 513-636-7449 email@example.com
Care of children with diabetes
Debra A. Standiford, MSN, APRN, CNP, has been an employee of Cincinnati Children's Hospital Medical Center since 1975.
From 1975 to 1977, Debra worked as a staff nurse on a chronic care unit, when she was promoted to charge nurse. She assumed the role of head nurse of the Orthopedic unit in 1978.
In 1980 and 1981, Debra worked part-time as a staff nurse on the Hematology/ Oncology unit and graduated with a bachelor's degree in nursing from the University of Cincinnati. She worked as pediatric extension program liaison in nursing education. The focus of her work was the coordination of clinical experiences for undergraduate nursing students from local universities, colleges, and schools of nursing.
Debra assisted in orienting newly employed nurses and presenting in-services for clinical and managerial nurses. During 1983 and 1984, she was acting director of Educational Services for Nursing and assumed the role of educational nurse specialist while pursuing further education. She graduated with a master's degree in nursing management from Indiana University in 1987. She was promoted to nursing director of the Neurosurgical/Tracheostomy unit.
In 1992, Debra assumed the role of diabetes research nurse. The major focus of her work was the coordination of clinical research studies related to diabetes in children and young adults.
Debra has completed postgraduate studies at the University of Cincinnati, and in 1989, was certified as a pediatric nurse practitioner. Currently, Debra works with families of children diagnosed with diabetes. She also continues to function as a coordinator of clinical research studies related to diabetes.
Diploma of Nursing: The Christ Hospital School of Nursing, Cincinnati, Ohio, 1975.
BSN: University of Cincinnati, Cincinnati, Ohio, 1981.
MSN: Nursing Administration, Indiana University, Indianapolis, Ind.,1987.
Certification: Pediatric Nurse Practitioner Program, University of Cincinnati, Cincinnati, Ohio, 1997.
Reynolds K, Liese AD, Anderson AM, Dabelea D, Standiford D, Daniels SR, Waitzfelder B, Case D, Loots B, Imperatore G, Lawrence JM. Prevalence of tobacco use and association between cardiometabolic risk factors and cigarette smoking in youth with type 1 or type 2 diabetes mellitus. J Pediatr. 2011 Apr;158(4):594-601.e1.
Liese AD, Bortsov A, Günther AL, Dabelea D, Reynolds K, Standiford DA, Liu L, Williams DE, Mayer-Davis EJ, D'Agostino RB Jr, Bell R, Marcovina S. Association of DASH diet with cardiovascular risk factors in youth with diabetes mellitus: the SEARCH for Diabetes in Youth study. Circulation. 2011 Apr 5;123(13):1410-7. Liese AD, Lawson A, Song HR, Hibbert JD, Porter DE, Nichols M, Lamichhane AP, Dabelea D, Mayer-Davis EJ, Standiford D, Liu L, Hamman RF, D'Agostino RB Jr. Evaluating geographic variation in type 1 and type 2 diabetes mellitus incidence in youth in four US regions. Health Place. 2010 May;16(3):547-56.
Writing Group for the SEARCH for Diabetes in Youth Study Group, Dabelea D, Bell RA, D'Agostino RB Jr, Imperatore G, Johansen JM, Linder B, Liu LL, Loots B, Marcovina S, Mayer-Davis EJ, Pettitt DJ, Waitzfelder B. Incidence of diabetes in youth in the United States. JAMA. 2007 Jun 27;297(24):2716-24.
Lawrence JM, Standiford DA, Loots B, Klingensmith GJ, Williams DE, Ruggiero A, Liese, AD, Bell RA, Waitzfelder BE, McKeown RE, for the SEARCH for Diabetes in Youth Study. Prevalence and Correlates of Depressed Mood among Youth with Diabetes: The SEARCH for Diabetes in Youth Study. Pediatrics. 2006; 117(4): 1348-1358.
SEARCH for Diabetes in Youth Study Group, Liese AD, D'Agostino RB Jr, Hamman RF, Kilgo PD, Lawrence JM, Liu LL, Loots B, Linder B, Marcovina S, Rodriguez B, Standiford D, Williams DE. The Burden of Diabetes Mellitus among US Youth: Prevalence Estimates from the SEARCH for Diabetes in Youth Study. Pediatrics. 2006;118(4): 1510-1518.Patton SR, Dolan LM, Mitchell MJ, Byars KC, Standiford D, Powers SW. Mealtime interactions in families of pre-schoolers with type 1 diabetes. Pediatr Diabetes. 2004 Dec;5(4):190-8. Powers SW, Byars KC, Mitchell MJ, Patton SR, Standiford DA, Dolan LM. Parent report of mealtime behavior and parenting stress in young children with type 1 diabetes and in healthy control subjects. Diabetes Care. 2002 Feb;25(2):313-8. Pinhas-Hamiel O, Standiford D, Hamiel D, Dolan LM, Cohen R, Zeitler PS. The type 2 family: a setting for development and treatment of adolescent type 2 diabetes mellitus. Arch Pediatr Adolesc Med. 1999 Oct;153(10):1063-7. Young LA, Kimball TR, Daniels SR, Standiford DA, Khoury PR, Eichelberger SM, Dolan LM. Nocturnal blood pressure in young patients with insulin-dependent diabetes mellitus: correlation with cardiac function. J Pediatr. 1998 Jul;133(1):46-50.
Karishma J. Tilton, MSN, APRN, CNP Nurse Practitioner, Diabetes Center 513-636-2444 firstname.lastname@example.org
Andrea N. Houchen, MSW, LISW-S
Social Worker II, Division of Social Services 513-636-2444 email@example.com
Craig R. McManiman, MSW, LISW
Social Worker III, Division of Social Services 513-636-2444 firstname.lastname@example.org
Maleshia Renee' Neugebauer
Social Worker, Diabetes Center 513-636-6076 email@example.com
3333 Burnet Avenue, Cincinnati, Ohio 45229-3026 | 1-513-636-4200 | 1-800-344-2462 | TTY: 1-513-636-4900
New to Cincinnati Children’s or live outside of the Tristate area? 1-877-881-8479
© 1999-2015 Cincinnati Children's Hospital Medical Center